A 50 % reduction in pain was achieved in 48.8 % of the bupivacaine group ( 20/41 patients ) versus 41.3 % in the normal saline solution group ( 19/46 patients ) , for an absolute risk difference of 7.5 % ( 95 % confidence interval [ CI ] -13 % to 27.1 % ) .